Microbes that cause diseases like HIV, malaria, and hepatitis C exploit and often activate the same checkpoint pathways —
cell surface receptors such as CTLA4 and PD - 1 — to slow immune cells and prevent their elimination by the host.
Not exact matches
The human body has about 1,000 kinds of
such receptors, structures on the
surface of
cells, which let the body respond to a wide variety of chemical signals, like adrenaline.
Most cancer vaccines developed to date have been designed to recognize and attack a specific known molecule —
such as a
cell -
surface receptor — that is likely to be found on cancerous
cells in any patient with that type of tumor.
In normal
cell function messenger chemicals,
such as various growth factors and insulin, bind to protein
receptors on the
cell's
surface.
A normal
cell has chemical
receptors on its
surface that link up with specific molecules generated by the body and control the timing of
such functions as eating and sleeping.
Antigen - presenting
cells (APCs),
such as dendritic
cells and macrophages, activate T
cells by engaging protein
receptors on the T
cell surface.
PDGFRα is a
cell surface tyrosine kinase
receptor involved in organ development and tumor progression, it is present in multiple
cell types
such as mesenchymal
cells, neurons, astrocytes, megakaryocytes and oligodendrocyte progenitor.
For example, Dr. Shiloh said, preventing Mtb from attaching to
receptors on the M -
cell surface —
such as by vaccinating against a bacterial protein — could block the bacteria's entry, infection, and spread to other organs.
Adenosine helps to sustain
such cells by fitting into a protein called the A2A adenosine
receptor on their
surfaces, like a key into a lock.
Receptors are proteins that are usually located on the external
surface of the
cell membrane; they provide specific recognition sites for messenger substances
such as hormones, neurotransmitters and growth factors.
In a major innovation reported last year, Lerner, Zhang and their colleagues developed a basic method for selecting antibodies that not only bind to a given target,
such as a
cell -
surface receptor, but also have a desired biological function —
such as activating the
receptor on mammalian
cells.
This work outlines how a
receptor termed LFA - 1 on the
surface of T -
cells mediates adhesion to other
cells such as cancer
cells.
We delve into very fundamental problems
such as «how does a malaria red blood
cell attach itself to a blood vessel» or «how does binding of a ligand to a
cell surface receptor or contact of a crystalline
surface with the plasma membrane drive lipid sorting and how will this lead to signalling» but then immediately apply it to a practical problem
such as «how does contact of uric acid crystals with dendritic
cells cause gout in affected joints and how can we prevent this occurrence?»
The pathways that connect expression of stem
cell surface glycoconjugates
such as the TRA -1-60 / GCTM - 2 antigen,
receptors, and growth factors in human and even mouse ES
cells with the transcriptional networks that regulate pluripotency remain unclear.